Clinical Oncology
Volume 18, Issue 3 , Pages 191-199 , April 2006

When May Adjuvant Radiotherapy be Avoided in Operable Breast Cancer?

  • I.H. Kunkler

      Affiliations

    • Department of Clinical Oncology, University of Edinburgh, Edinburgh, Scotland, UK
    • Corresponding Author InformationAuthor for correspondence: Dr Ian Kunkler, University Department of Clinical Oncology, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. Tel: +44-131-537-2214; Fax: +44-131-537-2216.
    • ,
  • R.J. Prescott

      Affiliations

    • Medical Statistics Unit, University of Edinburgh, Edinburgh, Scotland, UK
    • ,
  • L.J. Williams

      Affiliations

    • Medical Statistics Unit, University of Edinburgh, Edinburgh, Scotland, UK
    • ,
  • C.C. King

      Affiliations

    • Medical Statistics Unit, University of Edinburgh, Edinburgh, Scotland, UK

References 

  1. Hellman S. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229–2234
  2. Dodwell D, Horgan K. Breast cancer: loco-regional control and survival. Clin Oncol. 2001;13:172–173
  3. Overgaard M, Hansen PA, Overgaard J, et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–955
  4. Ragaz J, Jackson SM, Le N, et al. Postoperative radiotherapy in high-risk postmenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  5. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomised trial. J Natl Cancer Inst. 2005;97:116–126
  6. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients who receive adjuvant chemotherapy. Lancet. 1999;353:1641–1648
  7. Overgaard M. Update of the Danish trials of postoperative radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. In:  Kogelnik HD,  Lukas P,  Sedlmayer F editor. Progress in radio-oncology VII. Bologna: Monduzzi Editore; 2002;
  8. Scottish Executive. Cancer scenarios: an aid to planning cancer services in Scotland. Scottish Executive, May 2001.
  9. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;550–556
  10. Ballard-Barbash R, Potosky AL, Harlan LC, et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996;88:716–726
  11. Scottish Intercollegiate Guidelines Network. Breast cancer in women. A national clinical guideline. SIGN publication no 29, 1998.
  12. Kurtz J. EUSOMA working party. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer. 2002;38:1961–1974
  13. Zissiadis Y, Langlands A, Barraclough B, et al. Breast conservation: long term results from Westmead Hospital. Aust NZ J Surg. 1997;67:313–319
  14. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000;36:453–471
  15. Early Breast Cancer Trialists' Collaborative Group . Favourable and unfavourable effects on long-term survival for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757–1770
  16. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow up in a randomised clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:456–1461
  17. Clark RM, Whelan T, Levine ME, et al. Randomised clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Breast Cancer Study Group. J Natl Cancer Inst. 1996;88:1659–1664
  18. Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6 years analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708–713
  19. Sauer R, Wallgren A, Kurtz JM. Adjuvant radiotherapy after breast conserving surgery for breast cancer. Eur J Cancer. 2000;36:1073–1084
  20. Fortin A, Larochelle M, Laverdiere J, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17:101–109
  21. Vinh Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral tumour recurrence and mortality. J Natl Cancer Inst. 2004;96:115–121
  22. Fisher ER, Anderson S, Redmond C, et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Semin Surg Oncol. 1992;8:161–166
  23. Uppsala-Orebro Breast Cancer Study Group . Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst. 1990;82:277–282
  24. Liljegren G, Lindgren A, Bergh J, et al. Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol. 1997;8:235–241
  25. Clark RM, McCulloch PB, Levine MN, et al. Randomised clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node negative breast cancer. J Natl Cancer Inst. 1992;84:683–689
  26. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomised clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665–673
  27. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-conserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328:1587–1591
  28. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancers of the breast. Long-term results of three randomised trials on 1973 patients. Eur J Cancer. 1995;31A:1574–1579
  29. Schnitt SJ, McCready D, Manchul L, et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage 1 breast cancer. Cancer. 1996;77:1094–1100
  30. Hughes KS, Schnapper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–977
  31. Sacchini V, Borgen PI. Can radiation therapy for breast cancer be avoided?. Lancet. 2004;364:926–927
  32. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351:963–970
  33. Blamey R, Chetty U, George D, Morgan C, Mitchell M. Update of the BASO II trial of primary treatment of tumours of excellent prognosis. Eur J Cancer. 2004;(Suppl 2):161
  34. Kunkler IH. PRIME II breast cancer trial. Clin Oncol. 2004;16:447–448
  35. Tinterri C, Gatzemeier W, Andreoli C, et al. Breast conservative surgery with and without radiotherapy with early stage breast cancer: a prospective randomised trial. [abstract 378] Eur J Cancer Suppl. 2004;2(Suppl 3):166
  36. Goldhirsch A, Glick JH, Gelber R, et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst. 1998;90:1601–1608
  37. Harris JR, Halpin-Murphy P, McNeese M, et al. Consensus statement of postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:989–990
  38. Van der Hage JA, Putter H, Bonnema H, et al. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer. 2003;39:2192–2199
  39. Recht A, Edge SB, Solin LS, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  40. Recht A, Bartelink H, Fourquet A, et al. Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol. 1998;16:2886–2889
  41. Goldhirsch A, Coates AS, Colleoni M, Gelber R. Radiotherapy and chemotherapy in high-risk breast cancer. N Engl J Med. 1998;338:330
  42. Recht A, Gray R, Davidson NE, et al. Loco-regional failure ten years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation. Experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–1700
  43. Kaufmann MM, Jonat W, Abel U, et al. Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubcin/cyclophamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node positive breast cancer. J Clin Oncol. 1993;11:454–460
  44. Whelan T, Levine M. More evidence that locoregional radiation therapy improves survival: what should we do?. J Natl Cancer Inst. 2005;97:82–84
  45. Ceilley E, Jagel R, Goldberg S, et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys. 2005;61:365–373
  46. Voordeckers M, Van de Steene J, Vinh Hung V, et al. Adjuvant radiotherapy after mastectomy for pT1–pT2 node negative breast cancer (pN0): is it worth the effort?. Radiother Oncol. 2003;68:227–231
  47. Kunkler IH, Price A, Dixon JM, et al. SUPREMO (Selective Use of Postoperative Radiotherapy after Mastectomy): a phase III randomised trial assessing the role of postmastectomy chest wall irradiation in ‘intermediate risk’ women with operable breast cancer receiving adjuvant systemic therapy. International Congress of Radiation Research, Brisbane, Australia, 17–22 August 2003, poster abstract no 1159.
  48. Fowble B, Gray R, Gilchrist K, et al. Identifications of a subgroup of patients with breast cancer and histologically positive nodes receiving adjuvant chemotherapy who may benefit from postmastectomy radiotherapy. J Clin Oncol. 1988;6:1107–1117
  49. Sykes HF, Sims DA, Wong CJ, et al. Loco-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy: evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1989;16:641–647
  50. Pisanskya TM, Ingle JN, Schald DJ, et al. Patterns of tumour relapse following mastectomy and adjuvant systemic therapy in patients with axillary lymph node positive breast cancer. Cancer. 1993;72:1247–1260
  51. Katz A, Strom EA, Buchholz TA, et al. Loco-regional recurrence patterns after mastectomy and doxo-rubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 2000;18:2817–2827
  52. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage 1 and II breast cancer: pooled results of two large European randomised trials. J Clin Oncol. 2001;19:1688–1697
  53. O'Rourke S, Galea MH, Morgan D, et al. Local recurrence after simple mastectomy. Br J Surg. 1994;81:386–389
  54. Howells A, Cuzick J, Baum M, et al. Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years of adjuvant treatment. Lancet. 2005;365:60–62
  55. Hayman JA, Hillner BE, Harris JR, et al. Cost effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol. 1998;16:1022–1029
  56. Koscielny S, Tubiana M. The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:11–24
  57. Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomised trial. J Natl Cancer Inst. 1994;86:718–722

PII: S0936-6555(05)00441-3

doi: 10.1016/j.clon.2005.11.005

Clinical Oncology
Volume 18, Issue 3 , Pages 191-199 , April 2006

Article Tools